Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 23rd September 2022
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Professor Jacqui Matthews joins Austin Davis Biologics
Professor Jacqui Matthews.

She will take on the role of director of veterinary science.

Professor Jacqui Matthews has been appointed as director of veterinary science for Austin Davis Biologics (ADB), beginning on 14 November 2022.

The company deals in veterinary diagnostics and parasitology research, particularly in equine health. 

In her capacity as director of veterinary science, Professor Matthews will lead research and development activities, and will provide advice and support to clients who use the diagnostic test services through the use of webinars and training activities.

Dr Corrine Austin, founder and managing director of ABD, welcomed Professor Matthews to the team: “We are thrilled that Professor Matthews is joining our family-run veterinary diagnostic company. 

“Her input to ADB’s research programmes, as well as the wider equine parasitology field, is highly valued.”

After originally qualifying as a veterinary surgeon, Professor Matthews moved into the field of academia, and for 25 years has become renowned for her work in equine parasitology.

Professor Matthews is the inventor of the small redworm blood test, and has published over 140 peer-reviewed papers.

Discussing her new position, Professor Matthews said: “I am absolutely delighted to be joining ADB and given this opportunity to support and promote evidence based helminth control in horses in the UK and overseas. 

“I am also really looking forward to bringing more innovative diagnostics to the market to support animal health”.

Dr Austin added: “Not only do we have a busy future research program, but we hold a lot of information that hasn’t yet been published; Jacqui’s new position within ADB will accelerate future research as well dissemination of our existing research data.”

 

Image (C) Austin Davis Biologics

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.